Galectin Therapeutics Stock Forecast

Sell candidate since Jul 22, 2026

The Galectin Therapeutics Inc. stock price fell by -8.97% on the last day (Wednesday, 22nd Jul 2026) from $3.85 to $3.50. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 10.86% from a day low at $3.50 to a day high of $3.88. The price has fallen in 8 of the last 10 days and is down by -22.39% for this period. Volume has increased on the last day by 186 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 494 thousand shares were bought and sold for approximately $1.73 million.

Given the current short-term trend, the stock is expected to rise 96.78% during the next 3 months and, with a 90% probability hold a price between $6.89 and $11.04 at the end of this 3-month period.

GALT Signals & Forecast

There are few to no technical positive signals at the moment. The Galectin Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.26 and $3.63. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 14, 2026, and so far it has fallen -34.46%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.12 and $2.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galectin Therapeutics Inc. finds support just below today's level at $3.12. If this is broken, then the next support from accumulated volume will be at $2.79 and $2.70.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.380 between high and low, or 10.86%. For the last week, the stock has had daily average volatility of 10.10%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GALT) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Galectin Therapeutics Inc. to open at $3.63, and during the day (based on 14 day Average True Range), to move between $3.28 and $3.72, which gives a possible trading interval of +/-$0.442 (+/-13.47%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.12 (10.86%) than the resistance at $3.92 (12.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galectin Therapeutics Inc. stock A Buy?

The Galectin Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Galectin Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.219 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $3.63 ( 3.62%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk